Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Curr Treat Options Cardiovasc Med. 2013 Jun;15(3):299–312. doi: 10.1007/s11936-013-0234-9
Standard dosage 150 mg twice daily
75 mg twice daily (if creatinine clearance 15–30)
Contraindications Absolute: Active bleeding, renal impairment (creatinine clearance < 15)
Relative: Elevated bleeding risk, high-risk activities (extreme sports, certain occupations)
Main drug interactions Carbamazepine, cyclosporine, dronedarone, antifungals, quinidine, verapamil, rifampin
Main side effects Bleeding, dyspepsia/gastritis
Special points Direct thrombin inhibitor.
Similar safety and superior efficacy compared with warfarin [30].
No INR monitoring required.
Limited interaction with medication and food.
Patients need education regarding bleeding prevention.
No effective method to rapidly reverse anticoagulation effect.
Cost/cost-effectiveness Non-generic (approximate cost $246 per month). Periodic blood draws not required.